Published in:
Open Access
03-02-2023 | Metastasis | ASO Author Reflections
ASO Author Reflections: Safety and Feasibility of Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) with Three-Field Lymphadenectomy and Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer and Cervical Lymph Node Metastasis
Authors:
T. J. Weijs, MD, PhD, S. van der Horst, MSc, R. van Hillegersberg, MD, PhD
Published in:
Annals of Surgical Oncology
|
Issue 5/2023
Login to get access
Excerpt
Esophageal cancer remains a devastating disease, of which the incidence is increasing.
1 The cornerstone of treatment with curative intent is surgical resection. However, in case of preoperatively confirmed lymph node metastasis to the neck, patients are generally precluded surgery. The concurrent palliative treatment approach is associated with a limited 1 year survival of 32–39%. An alternative treatment approach would be neoadjuvant chemoradiotherapy followed by robot-assisted minimally invasive esophagectomy (RAMIE) with three-field lymphadenectomy, including the cervical lymph nodes. Whether this would be feasible and safe for the Western population was unclear up to now. …